Evidence map›Paper›PMID 32388879›Full record

ArticleJournal of viral hepatitis2020

Elevated liver stiffness without histological evidence of liver fibrosis in rural Ugandans.

Martin Tibuakuu, Caroline Jjingo, Gregory Dale Kirk, David Lee Thomas, Ronald Gray, Victor Ssempijja, Fred Nalugoda, David Serwadda, Ponsiano Ocama, Christopher Kenneth Opio and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of viral hepatitis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Martin TibuakuuDepartment of Medicine, St. Luke's Hospital, Chesterfield, Missouri, USA.
Caroline JjingoDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Gregory Dale KirkDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
David Lee ThomasDivision of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Ronald GrayDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Victor SsempijjaClinical Research Directorate/Clinical Monitoring Research Program, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland, USA.ORCID 0000-0003-2609-6525
Fred NalugodaRakai Health Sciences Program, Entebbe, Uganda.
David SerwaddaRakai Health Sciences Program, Entebbe, Uganda.
Ponsiano OcamaSchool of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Christopher Kenneth OpioSchool of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
David Erwin KleinerLaboratory of Pathology, National Institutes of Health, Bethesda, Maryland, USA.
Thomas Charles QuinnDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Steven James ReynoldsDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0002-5403-2759
National Institutes of Health · USJohns Hopkins University · USMakerere University · UGRakai Health Sciences Program · UGFrederick National Laboratory for Cancer Research · USSt. Luke's Hospital · US

Funding

International Center for Excellence in Research (ICER) in Uganda: Impact of ARVsZIAAI001040 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REYNOLDS, STEVEN · 2009 to 2025
$23.5M
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)ZIAAI000361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REDD, ANDREW · 2009 to 2025
$15.8M
Postmortem PathologyZICBC010685 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KLEINER, DAVID ERWIN · 2009 to 2025
$14.3M
The Role of HIV Infection in the Etiology and Clinical Manifestations of Hep CarcinomaU54CA190165 · NCI · JOHNS HOPKINS UNIVERSITY · PI KIRK, GREGORY D · 2014 to 2019
$4.2M
Patient-Oriented Research and Mentorship in HIV and Non-Communicable DiseasesK24AI118591 · NIAID · JOHNS HOPKINS UNIVERSITY · PI KIRK, GREGORY D · 2015 to 2019
$766k
CCR NIH HHS HHSN261200800001CIntramural NIH HHS ZIC BC010685National Institute of Allergy and Infectious Diseases K24-AI118591National Institute of Allergy and Infectious Diseases U54-CA190165NCI NIH HHS HHSN261200800001ENCI NIH HHS U54 CA190165NIAID NIH HHS K24 AI118591
6 · The paper itself

Abstract

Liver fibrosis may be assessed noninvasively with transient electrography (TE). Data on the performance of TE for detecting liver fibrosis in sub-Saharan Africa are limited. We evaluated the diagnostic accuracy of TE by performing liver biopsies on persons with liver fibrosis indicated by TE. We enrolled HIV-infected and HIV-uninfected participants with TE scores consistent with at least minimal disease (liver stiffness measurement [LSM]≥7.1 kPa). Biopsies were performed and staged using the Ishak scoring system. A concordant result was defined using accepted thresholds for significant fibrosis by TE (LSM ≥ 9.3 kPa) and liver biopsy (Ishak score ≥ 2). We used modified Poisson regression methods to quantify the univariate and adjusted prevalence risk ratios (PRR) of the association between covariates and the concordance status of TE and liver biopsy in defining the presence of liver fibrosis. Of 131 participants with valid liver biopsy and TE data, only 5 participants (3.8%) had Ishak score ≥ 2 of whom 4 had LSM ≥ 9.3 kPa (sensitivity = 80%); of the 126 (96.2%) with Ishak score < 2, 76 had LSM < 9.3 kPa (specificity = 61%). In multivariable analysis, discordance was associated with female gender (adjPRR = 1.80, 95%CI 1.1-2.9; P = .019), herbal medicine use (adjPRR 1.64, 95% CI = 1.0-2.5; P = .022), exposure to lake or river water (adjPRR 2.05, 95% CI = 1.1-3.7; P = .016), and current smoking (adjPRR 1.72, 95%CI 1.0-2.9; P = .045). These data suggest that TE among rural Ugandans has low specificity for detection of histologically confirmed liver fibrosis. Caution should be exercised when using this tool to confirm significant liver fibrosis.

Indexed as

Elasticity Imaging TechniquesBiopsyFemaleHumansLiverLiver CirrhosisUgandafibrosisHIVliver biopsyliver diseasetransient electrography

Identifiers

PMID32388879
PMCPMC8919060
OpenAlexW3023525401

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.